Meiji Holdings Co Ltd
TSE:2269

Watchlist Manager
Meiji Holdings Co Ltd Logo
Meiji Holdings Co Ltd
TSE:2269
Watchlist
Price: 3 129 JPY -0.22% Market Closed
Market Cap: 883B JPY
Have any thoughts about
Meiji Holdings Co Ltd?
Write Note

Net Margin
Meiji Holdings Co Ltd

4.7%
Current
7%
Average
3.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.7%
=
Net Income
53B
/
Revenue
1.1T

Net Margin Across Competitors

Country JP
Market Cap 864.3B JPY
Net Margin
5%
Country JP
Market Cap 53.2T JPY
Net Margin
4%
Country CH
Market Cap 190.5B CHF
Net Margin
12%
Country US
Market Cap 80.2B USD
Net Margin
11%
Country ZA
Market Cap 45.5B Zac
Net Margin
8%
Country FR
Market Cap 41.2B EUR
Net Margin
4%
Country MY
Market Cap 167.6B MYR
Net Margin
4%
Country US
Market Cap 37B USD
Net Margin
5%
Country ZA
Market Cap 35.9B Zac
Net Margin
14%
Country CN
Market Cap 258.3B CNY
Net Margin
23%
Country US
Market Cap 35.2B USD
Net Margin
13%
No Stocks Found

Meiji Holdings Co Ltd
Glance View

Market Cap
864.3B JPY
Industry
Food Products

Meiji Holdings Co., Ltd. has long been a staple in the world of Japanese consumer goods, specifically in the food and pharmaceutical sectors. Established in 2009 as a result of merging Meiji Seika Kaisha, Ltd. and Meiji Dairies Corporation, the company stands as a testament to the power of strategic consolidation, leveraging over a century of expertise from its predecessors. The company's robust product portfolio spans a diverse array of offerings, including dairy products like yogurts and milk, confectioneries like chocolate and candy, as well as nutrition bars and supplements. This triumvirate of product lines allows Meiji Holdings to position itself in both the everyday consumer market and in specialized health-centric industries, exploiting economies of scale and extensive distribution networks that reach far beyond the Japanese archipelago. In the pharmaceutical arena, Meiji Holdings operates under its subsidiary, Meiji Seika Pharma, focusing predominantly on antibacterial drugs, central nervous system treatments, and veterinary products. By integrating research and development with a comprehensive marketing strategy, the company capitalizes on global health trends and regional disease challenges, expanding in markets that emphasize health and dietary improvements. Financially, Meiji Holdings generates revenue by producing goods that tap into both traditional consumer desires and modern nutritional trends. It makes money by introducing high-margin pharmaceutical innovations alongside its well-established consumer brands, thus benefiting from both everyday sales and solutions aimed at pressing global health needs. Together, these strategic components make Meiji Holdings an agile player in a competitive global market, combining heritage with innovation.

Intrinsic Value
4 294.01 JPY
Undervaluation 27%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.7%
=
Net Income
53B
/
Revenue
1.1T
What is the Net Margin of Meiji Holdings Co Ltd?

Based on Meiji Holdings Co Ltd's most recent financial statements, the company has Net Margin of 4.7%.